Niels Borgstein, M.D. serves as Alkermes’ Senior Vice President of Late-Stage Clinical Development. In this role, Dr. Borgstein leads a team of clinical development physicians and clinical research scientists as well as the Medical Writing, Biostatistics and Drug Safety & Pharmacovigilance functions.
Dr. Borgstein has more than 20 years of international clinical research and drug development experience. Prior to joining Alkermes, he served as Vice President and Head of Clinical Development at Ironwood Pharmaceuticals. Earlier in his career, Dr. Borgstein held various leadership positions at SOTIO, Millennium/Takeda Oncology, Acceleron Pharma, Inc. and Pfizer.
Dr. Borgstein received his medical degree from the University Medical Center of Groningen in The Netherlands.